Data Insights
By Company Name
No filters selected
By Disease Name
No filters selected
By Drug Name
No filters selected
By Themes
No filters selected
Showing 1 results out of 1
Data Insights
ORYN-1001 by Oryn Therapeutics for Rheumatoid Arthritis: Likelihood of Approval
ORYN-1001 is under clinical development by Oryn Therapeutics and currently in Phase I for Rheumatoid Arthritis. According to GlobalData, Phase...